NovaBridge Biosciences (NBP) Operating cash flow 2019–2025
NovaBridge Biosciences (NBP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$20.6MFY2025 · since FY2019: -$124.7M → -$20.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.6M | +60.9% |
| FY2024 | -$52.7M | +71.3% |
| FY2023 | -$183.8M | -15.0% |
| FY2022 | -$159.9M | -4.7% |
| FY2021 | -$152.7M | -329.8% |
| FY2020 | $66.4M | +153.3% |
| FY2019 | -$124.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice